SKAN Group AG
SIX:SKAN

Watchlist Manager
SKAN Group AG Logo
SKAN Group AG
SIX:SKAN
Watchlist
Price: 48.95 CHF -1.21% Market Closed
Market Cap: 1.1B CHF

Operating Margin
SKAN Group AG

7.3%
Current
11%
Average
3.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
7.3%
=
Operating Profit
24.4m
/
Revenue
332.1m

Operating Margin Across Competitors

No Stocks Found

SKAN Group AG
Glance View

SKAN Group AG, headquartered in Switzerland, has carved out its niche as a leading innovator in the realm of contamination control for aseptic environments. The company's history traces back to its founding in 1968, following the rapid advancements in the pharmaceutical and biotechnology sectors. SKAN has since developed a sterling reputation for its pioneering work in isolator technology, offering solutions that ensure the highest standards of sterility and safety critical to these industries. The company designs and manufactures isolators, which are essentially sealed environments that provide contamination-free zones for the processing of materials or production of pharmaceuticals, ensuring that even the most sensitive products are handled with stringent safety measures. This focus on high-tech, specialized equipment forms the backbone of SKAN's revenue model. By providing bespoke solutions tailored to the unique requirements of its clients, SKAN taps into the lucrative markets of pharmaceutical production and research, biotechnology companies, and laboratories that demand high-performance contamination barriers. Beyond just the sale of equipment, SKAN also offers a comprehensive suite of services, including installation, validation, maintenance, and training, ensuring a steady flow of income as these businesses need continual updates and technical support for their critical infrastructure. The demand for stricter health regulations and more advanced pharmaceuticals continues to rise, positioning SKAN Group AG as a pivotal player in this essential industry, capitalizing on its expertise to ensure both safety and compliance for its customers worldwide.

SKAN Intrinsic Value
104.3 CHF
Undervaluation 53%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
7.3%
=
Operating Profit
24.4m
/
Revenue
332.1m
What is the Operating Margin of SKAN Group AG?

Based on SKAN Group AG's most recent financial statements, the company has Operating Margin of 7.3%.

Back to Top